FDA Brief

Company record

Nipro Renal Soultions USA, Corporation

0 FDA warning letters since 2023 and 4 recalls in the last 12 months.

Get an email the day FDA posts anything new about Nipro Renal Soultions USA, Corporation.

Recalls

ReportedClassFirmProduct and reason
Sep 16 Class II Nipro Renal Soultions USA, Corporation
Device
MedicaLyte Liquid Bicarbonate Concentrate REF: BC-100 and BC+201
Hemodialysis concentrates contain high endotoxin levels
Sep 16 Class II Nipro Renal Soultions USA, Corporation
Device
Citric Complete Liquid Citric Acid Concentrate REF: LC+200-D,LC+201, LC+225(45X)
Hemodialysis concentrates contain high endotoxin levels
Sep 16 Class II Nipro Renal Soultions USA, Corporation
Device
MedicaLyte Bicarbonate Powder REF: DB+201-2.1(45X) and DB+201-25 (35X, 36.83X, 45X))
Hemodialysis concentrates contain high endotoxin levels
Sep 16 Class II Nipro Renal Soultions USA, Corporation
Device
Citric Complete Dry Citric Acid Concentrate REF: DCA+200-25 & DCA+203-25
Hemodialysis concentrates contain high endotoxin levels